Joint Formulary & PAD

Ethinylestradiol - Menopausal disorders

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Not Specified
Associated Icons :
Restrictions / Comments :

PAD Profile

ChemicalSubstance :
Ethinylestradiol
Indication :
Menopausal disorders
Group Name :
Keywords :
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1

Other Indications

Below are listed other indications that Ethinylestradiol is used to treat.

Committee Recommendations (1)

The Surrey & North West Sussex Area Prescribing Committee updated their recommendations in line with NICE guidance NG23 Menopause diagnosis and management in May 2020.

Ethyinylestradiol is not recommended for menopausal symptoms and a NON-FOMULARY traffic light status is recommended.